Citation Impact
Citing Papers
Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
2009 StandoutNobel
Secondary BRCA1 Mutations in BRCA1 -Mutated Ovarian Carcinomas with Platinum Resistance
2008
Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors
2010
Effect of BRCA1/2 Mutations on Long-Term Survival of Patients With Invasive Ovarian Cancer: The National Israeli Study of Ovarian Cancer
2007
Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model
2015
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Cancer statistics, 2023
2023 Standout
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
Breast cancer
2019 Standout
Long noncoding RNAs in cancer: mechanisms of action and technological advancements
2016
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
2008
A molecular portrait of microsatellite instability across multiple cancers
2017
Cancer statistics, 2024
2024 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
High-Resolution Melting Analysis for Rapid Detection ofKRAS, BRAF,andPIK3CAGene Mutations in Colorectal Cancer
2008
Microsatellite instability in colorectal cancer—the stable evidence
2010
Targeting hypoxia in cancer therapy
2011 Standout
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity
2008
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
2014
A large fraction of unclassified variants of the mismatch repair genesMLH1andMSH2is associated with splicing defects
2008
Cancer Incidence in BRCA1 Mutation Carriers
2002
Breast cancer
2016 Standout
Microsatellite Instability in Colorectal Cancer
2010 Standout
Biological behavior and prognosis of familial papillary thyroid carcinoma
2008
Founder mutations in BRCA1 and BRCA2 genes
2007
Familial thyroid cancer: a review
2011
MuSiC: Identifying mutational significance in cancer genomes
2012
The missing linkage: what pharmacogenetic associations are left to find inCYP3A?
2009
Pancreatic cancer
2020 Standout
Ovarian cancer
2014 Standout
Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction
2017
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Pancreatic cancer
2016 Standout
Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants
2019
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
2009
Second international consensus guidelines for breast cancer in young women (BCY2)
2016
Familial nonmedullary thyroid carcinoma—clinical relevance and prognosis. A European multicenter study
2010
Current Management Strategies for Ovarian Cancer
2007
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
2011
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
DNA Damage, Aging, and Cancer
2009 Standout
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
2009 Standout
DNA mismatch repair defects: role in colorectal carcinogenesis
2002
A review of PARP inhibitors: from bench to bedside
2010
Inherited Pancreatic Cancer Syndromes
2012
Risk of Endometrial Carcinoma Associated with BRCA Mutation
2001
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50 000 individuals
2009
Risk of second primary cancer following differentiated thyroid cancer
2004
Resistance to therapy caused by intragenic deletion in BRCA2
2008 Nature
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Identification and Survival of Carriers of Mutations in DNA Mismatch-Repair Genes in Colon Cancer
2006
Occult Carcinoma in Prophylactic Oophorectomy Specimens
2001
Management of BRCA1/2 associated breast cancer: A systematic qualitative review of the state of knowledge in 2006
2006
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria
2013
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
2009 Standout
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Association Between <emph type="ital">BRCA1</emph> and <emph type="ital">BRCA2</emph> Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
2012
Maftools: efficient and comprehensive analysis of somatic variants in cancer
2018 Standout
The MLH1 D132H variant is associated with susceptibility to sporadic colorectal cancer
2004
Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients
2007
Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin–Cohort Study in Ontario, Canada
2006
First international consensus guidelines for breast cancer in young women (BCY1)
2014
Preservation of Fertility in Patients with Cancer
2009 Standout
Young-onset colorectal cancer
2023
BRCA germline mutations in Jewish women with uterine serous papillary carcinoma
2004
Cancer of the Ovary
2004 Standout
On the Prevalence of Familial Nonmedullary Thyroid Cancer in Multiply Affected Kindreds
2006
In Patients with Thyroid Cancer of Follicular Cell Origin, a Family History of Nonmedullary Thyroid Cancer in One First-Degree Relative Is Associated with More Aggressive Disease
2011
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
2012
Secondary Somatic Mutations RestoringBRCA1/2Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
2011
Inferring tumour purity and stromal and immune cell admixture from expression data
2013 Standout
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
2012 Standout
Emerging cancer incidence trends in Canada: The growing burden of young adult cancers
2020
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Breast Cancer Statistics, 2022
2022 Standout
Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer
2012
Current Management Strategies for Ovarian Cancer
2007
2015
Ovarian cancer statistics, 2018
2018 Standout
Breast Cancer Treatment
2019 Standout
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
2010
<p>A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of <em>BRCA</em>-mutated breast cancer</p>
2019
Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations
2009
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1
2012 Standout
International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
2017
Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule
2012
Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA Mutations
2003
A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
2008
Why have ovarian cancer mortality rates declined? Part I. Incidence
2015
Familial Risks for Nonmedullary Thyroid Cancer
2005
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Impairment of BRCA1-Related DNA Double-Strand Break Repair Leads to Ovarian Aging in Mice and Humans
2013
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Works of Tuya Pal being referenced
Association between CYP3A4 genotype and risk of endometrial cancer following tamoxifen use
2007
A Pooled Case-only Analysis of Reproductive Risk Factors and Breast Cancer Subtype Among Black Women in the Southeastern United States
2021
Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implications
2001
Mismatch Repair Gene Defects Contribute to the Genetic Basis of Double Primary Cancers of the Colorectum and Endometrium
1999
Fertility in women with BRCA mutations: a case-control study
2009
Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers
2018
International Rates of Breast Reconstruction After Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers
2013
A review of the clinical relevance of mismatch‐repair deficiency in ovarian cancer
2008
Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?
2000
The presence of germ line mosaicism in cleidocranial dysplasia
2007
Improved survival in BRCA2 carriers with ovarian cancer
2006
A Comprehensive Analysis ofMNG1,TCO1,fPTC,PTEN,TSHR, and TRKA in Familial Nonmedullary Thyroid Cancer: Confirmation of Linkage to TCO1
2001
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
2005
Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium?
2000
Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2
2012
Endometrial Cancer Risk Is Associated with Variants of the Mismatch Repair Genes MLH1 and MSH2
2006
Racial disparities in BRCA testing and cancer risk management across a population‐based sample of young breast cancer survivors
2017
Factors Which Impact the Delivery of Genetic Risk Assessment Services Focused on Inherited Cancer Genomics: Expanding the Role and Reach of Certified Genetics Professionals
2013
Systematic Review and Meta-analysis of Ovarian Cancers: Estimation of Microsatellite-High Frequency and Characterization of Mismatch Repair Deficient Tumor Histology
2008
Estrogen Bioactivation, Genetic Polymorphisms, and Ovarian Cancer
2005
A high frequency of BRCA mutations in young black women with breast cancer residing in Florida
2015
BRCA1 and BRCA2 Mutations in a Study of African American Breast Cancer Patients
2004
BRCA1 and BRCA2 mutations in a study of African American breast cancer patients.
2004
Increased Risk for Nonmedullary Thyroid Cancer in the First Degree Relatives of Prevalent Cases of Nonmedullary Thyroid Cancer: A Hospital-Based Study
2001